In support of mitochondrial replacement therapy

Eli Y Adashi¹, Arthur L Caplan², Alexander Capron³, Audrey R Chapman⁴, Mildred Cho⁵, Ellen Wright Clayton⁶, I Glenn Cohen⁷, Robert Cook-Deegan⁸, Ruth R Faden⁹, Theodore Friedmann¹⁰, Lawrence O Gostin¹¹, Henry T Greely¹², Josephine Johnston¹³, Eric Juengst¹⁴, Patricia A King¹¹, Lori P Knowles¹⁵, Anne Drapkin Lyerly¹⁴, Amy L McGuire¹⁶, Jonathan D Moreno¹⁷, Karen Rothenberg¹⁸, Robert D Truog¹⁹, LeRoy Walters²⁰

Affiliations

¹ Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
² Department of Population Health, New York University School of Medicine, New York, NY, USA.
³ Gould School of Law, University of Southern California, Los Angeles, California, USA.
⁴ Department of Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, CT, USA.
⁵ Center for Biomedical Ethics, Stanford University, Palo Alto, CA, USA.
⁶ Center for Biomedical Ethics and Society, Vanderbilt University, Nashville, TN, USA.
⁷ Law School, Harvard University, Cambridge, MA, USA.
⁸ School for the Future of Innovation in Society, Arizona State University, Tempe, AZ, USA. bcd@asu.edu.
⁹ Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
¹⁰ Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
¹¹ School of Law, Georgetown University, Washington DC, USA.
¹² Law School, Stanford University, Palo Alto, CA, USA.
¹³ The Hastings Center, Garrison, NY, USA.
¹⁴ Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
¹⁵ School of Public Health, University of Alberta, Edmonton, Alberta, Canada. loripknowles@gmail.com.
¹⁶ Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
¹⁷ Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA, USA.
¹⁸ Carey School of Law, University of Maryland, Baltimore, MD, USA.
¹⁹ Medical School, Harvard University, Boston, MA, USA.
²⁰ Kennedy Institute of Ethics, Georgetown University, Washington, DC, USA.

PMID: 31160819
DOI: 10.1038/s41591-019-0477-4

In support of mitochondrial replacement therapy

Eli Y Adashi et al. Nat Med. 2019 Jun.

. 2019 Jun;25(6):870-871.

doi: 10.1038/s41591-019-0477-4.

Authors

Affiliations

¹ Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
² Department of Population Health, New York University School of Medicine, New York, NY, USA.
³ Gould School of Law, University of Southern California, Los Angeles, California, USA.
⁴ Department of Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, CT, USA.
⁵ Center for Biomedical Ethics, Stanford University, Palo Alto, CA, USA.
⁶ Center for Biomedical Ethics and Society, Vanderbilt University, Nashville, TN, USA.
⁷ Law School, Harvard University, Cambridge, MA, USA.
⁸ School for the Future of Innovation in Society, Arizona State University, Tempe, AZ, USA. bcd@asu.edu.
⁹ Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
¹⁰ Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
¹¹ School of Law, Georgetown University, Washington DC, USA.
¹² Law School, Stanford University, Palo Alto, CA, USA.
¹³ The Hastings Center, Garrison, NY, USA.
¹⁴ Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
¹⁵ School of Public Health, University of Alberta, Edmonton, Alberta, Canada. loripknowles@gmail.com.
¹⁶ Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
¹⁷ Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA, USA.
¹⁸ Carey School of Law, University of Maryland, Baltimore, MD, USA.
¹⁹ Medical School, Harvard University, Boston, MA, USA.
²⁰ Kennedy Institute of Ethics, Georgetown University, Washington, DC, USA.

PMID: 31160819
DOI: 10.1038/s41591-019-0477-4

No abstract available

PubMed Disclaimer

References

1. Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception (HFEA, 2011).
1. Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception (HFEA, 2013).
1. Third Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception : 2014 Update (HFEA, 2014).
1. Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception : 2016 Update (HFEA, 2016).
1. Novel Techniques for the Prevention of Mitochondrial DNA Disorders: An Ethical Review (Nuffield Council on Bioethics, 2012).

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

In support of mitochondrial replacement therapy

Affiliations

In support of mitochondrial replacement therapy

Authors

Affiliations

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical